The Navigator Company, S.A. (ELI:NVG)
Portugal
· Delayed Price · Currency is EUR | Market Cap | 2.36B |
| Revenue (ttm) | 1.98B |
| Net Income (ttm) | 144.67M |
| Shares Out | 711.18M |
| EPS (ttm) | 0.20 |
| PE Ratio | 16.32 |
| Forward PE | 14.40 |
| Dividend | 0.11 (3.41%) |
| Ex-Dividend Date | n/a |
| Volume | 429,612 |
| Average Volume | 748,236 |
| Open | 3.280 |
| Previous Close | 3.294 |
| Day's Range | 3.272 - 3.330 |
| 52-Week Range | 2.888 - 3.666 |
| Beta | 0.24 |
| RSI | 45.56 |
| Earnings Date | May 7, 2026 |
About The Navigator Company
The Navigator Company, S.A. manufactures and markets pulp and paper products worldwide. It operates through Market Pulp, UWF Paper, Tissue Paper, Biomass Renewable Energy, and Support segments. The company produces bleached eucalyptus kraft pulp, uncoated writing and printing thin paper, and domestic consumption paper under the Navigator, Inacopia, and Pioneer brands for professional and home use. It also operates cogeneration units; and two independent thermoelectric power plants. The company was formerly known as Portucel, S.A. and changed it... [Read more]
Financial Performance
In 2025, The Navigator Company's revenue was 1.98 billion, a decrease of -5.81% compared to the previous year's 2.10 billion. Earnings were 144.67 million, a decrease of -49.58%.
Financial StatementsNews
The Navigator Company Earnings Call Transcript: Q4 2025
Despite a challenging year with sharp price declines and weak demand, diversified operations in tissue and packaging drove resilient earnings and market share gains. Strategic investments and efficiency initiatives position the group for growth and margin improvement in 2026.
The Navigator Company Earnings Call Transcript: Q3 2025
Resilience in volatile markets was achieved through diversification, cost optimization, and operational excellence, with strong performance in tissue and packaging offsetting weaker pulp and paper prices. Financial discipline and sustainability investments underpin a robust outlook, despite ongoing macroeconomic risks.
The Navigator Company Earnings Call Transcript: Q2 2025
Turnover reached EUR 1.019 billion in H1 2025, with strong growth in tissue and packaging segments and EBITDA of EUR 216 million, down 28% year-on-year. Strategic investments and cost optimization initiatives are underway amid volatile market conditions and new U.S. tariffs.
The Navigator Company Earnings Call Transcript: Q1 2025
Solid Q1 performance with 2% revenue growth and stable EBITDA margin, driven by strong tissue and packaging segments. Strategic investments and diversification support resilience amid volatile energy costs and market uncertainty. Flexible packaging and tissue now account for 45% of sales.
The Navigator Company Earnings Call Transcript: Q4 2024
Turnover rose 7% to EUR 2.09 billion, with EBITDA at EUR 547 million and net profit up 4%. Business diversification, cost reductions, and international expansion drove strong results, while investments in sustainability and innovation continued. Dividend of EUR 175 million proposed.
The Navigator Company Earnings Call Transcript: Q3 2024
Strong Q3 and nine-month results driven by growth in tissue and packaging, cost reductions, and successful integration of acquisitions. Outlook remains positive despite macroeconomic uncertainties, with continued focus on innovation, sustainability, and operational efficiency.
The Navigator Company Earnings Call Transcript: H1 2024
Delivered strong H1 2024 results with 9% revenue growth, 28% EBITDA margin, and robust net profit. Expanded tissue segment via Accrol acquisition, reduced costs across all segments, and maintained a strong financial position.